Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chamieh, Carolla El"'
Autor:
Chamieh, Carolla El1 (AUTHOR), Larabi, Islam Amine2,3 (AUTHOR), Pinho, Natalia Alencar De1 (AUTHOR) natalia.alencar-de-pinho@inserm.fr, Lambert, Oriane1 (AUTHOR), Combe, Christian4,5 (AUTHOR), Fouque, Denis6,7 (AUTHOR), Frimat, Luc8,9 (AUTHOR), Jacquelinet, Christian1,10 (AUTHOR), Laville, Maurice7 (AUTHOR), Laville, Solène11,12 (AUTHOR), Lange, Céline1 (AUTHOR), Alvarez, Jean-Claude2,3 (AUTHOR), Massy, Ziad A1,13 (AUTHOR) ziad.massy@aphp.fr, Liabeuf, Sophie11,12 (AUTHOR) liabeuf.sophie@chu-amiens.fr, Group, the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study (AUTHOR)
Publikováno v:
Clinical Kidney Journal. Jan2024, Vol. 17 Issue 1, p1-10. 10p.
Autor:
Maalouf G; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France., Andrillon A; Department of Biostatistics and Medical Information, CRESS UMR 1153, INSERM, ECSTRRA Team, Saint-Louis University Hospital, AP-HP, University of Paris, Paris, France., Leclercq M; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France; Internal Medicine Department, CHU Rouen, Rouen, France., Sève P; Internal Medicine Department, Hôpital de la Croix- Rousse, Hospices Civils de Lyon, Lyon Cedex, France; Faculté de Médecine Lyon-Sud, Université Claude Bernard-Lyon 1, Lyon, France., Bielefeld P; Internal Medicine and Systemic Diseases Department (Medicine Interne 2), Dijon University hospital, Dijon, France., Gueudry J; Ophthalmology Department, Hospital Charles Nicolle, CHU Rouen, Rouen, France; EA7510, UFR Santé, Rouen University, Rouen, France., Sené T; Internal Medicine Department, Fondation Rothschild, Paris, France., Titah C; Ophthalmology Department, Fondation Rothschild, Paris, France., Moulinet T; Department of Internal Medicine, CHRU de Nancy, Nancy, France; Université de Lorraine, Inserm UMR_S 1116, Nancy, France., Rouvière B; Internal Medicine and Pneumology Department, CHU de Brest, Hôpital La Cavale Blanche, Brest Cedex, France., Sène D; Internal Medicine Department, Lariboisière Hospital, Paris, France; INSERM UMR, Paris Diderot University, Paris, France., Desbois AC; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France., Domont F; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France., Touhami S; Ophthalmology Department, DHU View Restore, Pitié Salpêtrière Hospital, Paris, France., Thibault T; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France., Chamieh CE; Department of Biostatistics and Medical Information, CRESS UMR 1153, INSERM, ECSTRRA Team, Saint-Louis University Hospital, AP-HP, University of Paris, Paris, France., Cacoub P; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France., Kodjikian L; Ophthalmology Department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon Cedex, France; Faculté de Médecine Lyon-Sud, Université Claude Bernard-Lyon 1, Lyon, France., Biard L; Department of Biostatistics and Medical Information, CRESS UMR 1153, INSERM, ECSTRRA Team, Saint-Louis University Hospital, AP-HP, University of Paris, Paris, France., Bodaghi B; Ophthalmology Department, DHU View Restore, Pitié Salpêtrière Hospital, Paris, France., Saadoun D; From the Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire; INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France. Electronic address: david.saadoun@aphp.fr.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2022 Jun; Vol. 238, pp. 173-180. Date of Electronic Publication: 2022 Feb 13.